ARCHIVES

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

This article is from The Cancer Letter archive.

Vol. 32 No. 42 | November 22, 2006

Download PDF Visit The Full Archive

Related Articles

NCI May Seek Cuts In R01s, P01s If Congress Approves Rescission

January 30, 1981

FDA To Regulate Products From Human Cells, Tissue

March 21, 1997

AACI Told Medicare “Probably” Has Paid For Extra Patient Care Costs Of Research; Members Object To “Two Level System”

July 27, 1984

HHS Inspector General: Busy Signals Greet One In Three Callers To 800-4-CANCER

July 24, 1998

HPV Vaccine Cervarix Active In 100% Of Women In Study

July 27, 2007

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009